Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Income After Tax (2009 - 2026)

Updated

Dr Reddys Laboratories' Income After Tax came in at $95.56 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.6% from $163.58 million a year earlier but up 108.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Income After Tax (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Dr Reddys Laboratories reported Income After Tax of $299.19 million, down 55.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $481.13 million, down 28.3% from FY2025.

  • Income After Tax carries a five-year compound annual growth rate of 15.3% (FY2021 to FY2026).
  • Going back by fiscal year, Income After Tax was $671 million in FY2025 (+0.4%), $668 million in FY2024 (+21.9%), $548 million in FY2023 (+76.2%) and $311 million in FY2022 (+31.8%).
  • The five-year range for quarterly Income After Tax is $11.64 million (fiscal Q4 2022) to $183.3 million (fiscal Q4 2025).
  • Year-over-year, Income After Tax has declined for four consecutive quarters, with an average decline of 25.3% over the last eight quarters.
  • The fastest year-over-year change in Income After Tax over five years came in fiscal Q3 2023 (growth of 143.8%), and the weakest in fiscal Q4 2026 (a decline of 86.8%).
  • Business Quant data shows RDY's Income After Tax at $45.93 million (Q1 2027), $24.12 million (Q4 2026) and $133.59 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 210.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 4.22 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 4.80 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 3.25 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 95.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 95.56 Mn
Jun 30, 2026 45.93 Mn
Mar 31, 2026 24.12 Mn
Dec 31, 2025 133.59 Mn
Sep 30, 2025 163.58 Mn
Jun 30, 2025 164.71 Mn
Mar 31, 2025 183.30 Mn
Dec 31, 2024 166.26 Mn
Sep 30, 2024 160.17 Mn
Jun 30, 2024 166.87 Mn
Mar 31, 2024 157.38 Mn
Dec 31, 2023 165.60 Mn
Sep 30, 2023 179.04 Mn
Jun 30, 2023 170.00 Mn
Mar 31, 2023 169.00 Mn
Dec 31, 2022 117.00 Mn
Sep 30, 2022 152.00 Mn
Jun 30, 2022 135.00 Mn
Mar 31, 2022 11.64 Mn
Dec 31, 2021 48.00 Mn
API Access

Dr Reddys Laboratories Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RDY&period=max&api_key=YOUR_API_KEY